> MNTA – That's wonderful news! …My heartiest congrats to all the Momenta holders! Hi Dew, Your story stock is becoming real <
Yes, this is great news for MNTA. But MNTA is still a story stock until the FDA approves MNTA’s generic Lovenox and rejects (or takes no action on) the generic-Lovenox applications from TEVA and Amphistar. Only then will investors have undisputable proof that MNTA’s technology can form the basis of a lucrative business.
In the meantime, enjoy the ride. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”